Stock Analysis

Market Participants Recognise Chindata Group Holdings Limited's (NASDAQ:CD) Earnings Pushing Shares 35% Higher

Source: Shutterstock

Those holding Chindata Group Holdings Limited (NASDAQ:CD) shares would be relieved that the share price has rebounded 35% in the last thirty days, but it needs to keep going to repair the recent damage it has caused to investor portfolios. Unfortunately, the gains of the last month did little to right the losses of the last year with the stock still down 20% over that time.

Following the firm bounce in price, given close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 14x, you may consider Chindata Group Holdings as a stock to avoid entirely with its 28.4x P/E ratio. Although, it's not wise to just take the P/E at face value as there may be an explanation why it's so lofty.

Recent times have been advantageous for Chindata Group Holdings as its earnings have been rising faster than most other companies. It seems that many are expecting the strong earnings performance to persist, which has raised the P/E. If not, then existing shareholders might be a little nervous about the viability of the share price.

Our analysis indicates that CD is potentially undervalued!

NasdaqGS:CD Price Based on Past Earnings December 1st 2022
Keen to find out how analysts think Chindata Group Holdings' future stacks up against the industry? In that case, our free report is a great place to start.

Does Growth Match The High P/E?

In order to justify its P/E ratio, Chindata Group Holdings would need to produce outstanding growth well in excess of the market.

Taking a look back first, we see that the company grew earnings per share by an impressive 263% last year. Although, its longer-term performance hasn't been as strong with three-year EPS growth being relatively non-existent overall. So it appears to us that the company has had a mixed result in terms of growing earnings over that time.

Shifting to the future, estimates from the nine analysts covering the company suggest earnings should grow by 17% per annum over the next three years. Meanwhile, the rest of the market is forecast to only expand by 9.0% each year, which is noticeably less attractive.

With this information, we can see why Chindata Group Holdings is trading at such a high P/E compared to the market. Apparently shareholders aren't keen to offload something that is potentially eyeing a more prosperous future.

The Final Word

Chindata Group Holdings' P/E is flying high just like its stock has during the last month. Typically, we'd caution against reading too much into price-to-earnings ratios when settling on investment decisions, though it can reveal plenty about what other market participants think about the company.

As we suspected, our examination of Chindata Group Holdings' analyst forecasts revealed that its superior earnings outlook is contributing to its high P/E. At this stage investors feel the potential for a deterioration in earnings isn't great enough to justify a lower P/E ratio. Unless these conditions change, they will continue to provide strong support to the share price.

We don't want to rain on the parade too much, but we did also find 1 warning sign for Chindata Group Holdings that you need to be mindful of.

If you're unsure about the strength of Chindata Group Holdings' business, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.

What are the risks and opportunities for Chindata Group Holdings?

Chindata Group Holdings Limited provides carrier-neutral hyper scale data center solutions in China, India, Malaysia, and Southeast Asia.

View Full Analysis


  • Trading at 18.4% below our estimate of its fair value

  • Earnings are forecast to grow 25% per year

  • Earnings grew by 272.1% over the past year


  • High level of non-cash earnings

View all Risks and Rewards

Share Price

Market Cap

1Y Return

View Company Report

Further research on
Chindata Group Holdings

ValuationFinancial HealthInsider TradingManagement Team